CN101918574A - 大规模的微生物培养法 - Google Patents
大规模的微生物培养法 Download PDFInfo
- Publication number
- CN101918574A CN101918574A CN2007801019569A CN200780101956A CN101918574A CN 101918574 A CN101918574 A CN 101918574A CN 2007801019569 A CN2007801019569 A CN 2007801019569A CN 200780101956 A CN200780101956 A CN 200780101956A CN 101918574 A CN101918574 A CN 101918574A
- Authority
- CN
- China
- Prior art keywords
- oxygen
- substratum
- microorganism
- condition
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 238000009629 microbiological culture Methods 0.000 title description 2
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 149
- 239000001301 oxygen Substances 0.000 claims abstract description 149
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 145
- 239000002253 acid Substances 0.000 claims abstract description 34
- 239000002207 metabolite Substances 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 29
- 244000005700 microbiome Species 0.000 claims description 28
- 101150014383 adhE gene Proteins 0.000 claims description 24
- 101150041530 ldha gene Proteins 0.000 claims description 22
- 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 claims description 21
- 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 claims description 21
- 101150067967 iclR gene Proteins 0.000 claims description 21
- 101150026107 ldh1 gene Proteins 0.000 claims description 21
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 230000002779 inactivation Effects 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 6
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 6
- 230000002018 overexpression Effects 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 5
- 101150096049 pyc gene Proteins 0.000 claims description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 238000012239 gene modification Methods 0.000 claims description 3
- 230000005017 genetic modification Effects 0.000 claims description 3
- 235000013617 genetically modified food Nutrition 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- 101150108780 pta gene Proteins 0.000 claims 2
- 238000005215 recombination Methods 0.000 claims 2
- 230000006798 recombination Effects 0.000 claims 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 1
- 101100340279 Sphingobium yanoikuyae icd gene Proteins 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- 101150034989 idhA gene Proteins 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 238000010926 purge Methods 0.000 claims 1
- 239000002028 Biomass Substances 0.000 abstract description 12
- 238000012136 culture method Methods 0.000 abstract description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- 230000001580 bacterial effect Effects 0.000 description 35
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 34
- 239000008103 glucose Substances 0.000 description 33
- 238000004519 manufacturing process Methods 0.000 description 28
- 238000003756 stirring Methods 0.000 description 19
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 10
- 230000012010 growth Effects 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 235000011089 carbon dioxide Nutrition 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000003513 alkali Substances 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 229960003311 ampicillin trihydrate Drugs 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 238000011533 pre-incubation Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229930003756 Vitamin B7 Natural products 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- 239000011735 vitamin B7 Substances 0.000 description 6
- 235000011912 vitamin B7 Nutrition 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 206010021143 Hypoxia Diseases 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 208000018875 hypoxemia Diseases 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 150000002926 oxygen Chemical class 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 108010071189 phosphoenolpyruvate-glucose phosphotransferase Proteins 0.000 description 4
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 108010046845 tryptones Proteins 0.000 description 4
- 238000009423 ventilation Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000452638 Parasaissetia nigra Species 0.000 description 3
- 101100462488 Phlebiopsis gigantea p2ox gene Proteins 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 150000001721 carbon Chemical class 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940049920 malate Drugs 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 3
- 101150060030 poxB gene Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 2
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010564 aerobic fermentation Methods 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000013530 defoamer Substances 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012269 metabolic engineering Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 108020003285 Isocitrate lyase Proteins 0.000 description 1
- 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 1
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 1
- 238000002806 Stokes method Methods 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 101150094017 aceA gene Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
- 101150070136 axeA gene Proteins 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- FJEKYHHLGZLYAT-FKUIBCNASA-N galp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(O)=O)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C1=CNC=N1 FJEKYHHLGZLYAT-FKUIBCNASA-N 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- NIWMEUWZZDPUEQ-UHFFFAOYSA-M sodium;azane;hydroxide Chemical compound N.[OH-].[Na+] NIWMEUWZZDPUEQ-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/065—Ethanol, i.e. non-beverage with microorganisms other than yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/16—Butanols
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
- C12P7/20—Glycerol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Abstract
Description
批号 | 在富氧期中初始的搅拌(RPM) | 在富氧期中最终的搅拌(RPM) | 气流速率(L/min) | 碱 | 摩尔产率 | 比速率(g/L/h/OD) |
30 | 800 | 800 | 2.5 | NaCO3 | -1.4 | 0.06< |
批号 | 在富氧期中初始的搅拌(RPM) | 在富氧期中最终的搅拌(RPM) | 气流速率(L/min) | 碱 | 摩尔产率 | 比速率(g/L/h/OD) |
31 | 50 | 50 | 1.5 | NaCO3 | -1.6 | >0.10 |
一种钾和磷源(例如K2HPO4) |
一种硫源(例如(NH4)2SO4) |
一种镁源(例如MgSO4-7H2O) |
一种钙源(例如CaCl2) |
一种铁源(例如硫酸铁) |
一种微量元素源(例如Cu、Zn、Co、Ni、B、Ti的盐类) |
水 |
如有必要一种pH缓冲液 |
一个或多个碳源,优选有机的(酵母提取物、葡萄糖、甘油、淀粉、玉米副产物类、等等。) |
一个或多个氮源(酵母提取物、玉米浆等等) |
葡萄糖 | 2g |
胰蛋白胨 | 20g |
酵母提取物 | 10g |
(NH4)2HPO4 | 3g |
KH2PO4 | 1.2g |
K2HPO4 | 0.7g |
MgSO4 | 0.25g |
CaCl2 | 0.2g |
硫胺素 | 0.99mg |
生物素 | 1mg |
水 | 使体积至1000mL |
葡萄糖 | 10g |
(NH4)2HPO4 | 6g |
K2HPO4 | 0.5g |
K2SO4 | 1g |
KCL | 2g |
MgSO4.H2O | 2g |
H3BO3 | 1mg |
MnSO4-7H2O | 20mg |
ZnSO4-7H2O | 4mg |
CuClr-2H2O | 2mg |
CaClr-2H2O | 30mg |
FeSO4-7H2O | 60mg |
CoClr-6H2O | 8mg |
Na2MO42H2O | 0.4mg |
生物素 | 1mg |
硫胺素 | 1mg |
蒸馏水 | 使体积至1000mL |
ΔadhE | 醇脱氢酶失活 |
ΔldhA | 乳酸脱氢酶失活 |
ΔiclR | 异柠檬酸裂合酶(也被称为aceA)失活 |
Δackpta | 乙酸激酶和磷酸转乙酰酶的失活,可以由一种菌株替代,其中乙酸激酶或磷酸转乙酰酶之一(Δack或Δpta)是失活的 |
PYC | 一种丙酮酸羧化酶基因的表达。这表明该菌株表达了PYC基因,例如借助于使用携带该基因的一个功能拷贝的质粒进行转化,或通过PYC的一个功能拷贝的基因组整合。PYC基因有利地是乳酸乳球菌的PYC基因。 |
菌株 | 基因型 |
SBSII0MG | adhE ldhA,Kms |
SBS330MG | adhE ldhA iclR,Kms |
SBS440MG | adhE,ldhA,iclR,areA,Kms |
SBS550MG | adhE ldhA iclR Δaekpta::CmR,Kms |
SBS550-P | adhE ldhA iclR,poxB,Δaekpta |
SBS550MG/ptsG | adhE ldhA iclR,ptsG,Δaekpta::CmR,Kms, |
SBS660MG | adhE,ldhA,iclR,areA,Δaekpta::CmR,Kms, |
SBS990MG | adhE ldhA,Δaekpta::CmR,Kms, |
SBS551MG | adhE ldhA iclR,sdhAB Δaekpta::CmR,Kms |
SBS552MG | adhE ldhA iclR,poxB,sdhAB Δaekpta::CmR,Kms |
SBS552MG/ptsG | adhE ldhA iclR,ptsG,poxB,sdhAB Δaekpta::CmR,Kms |
PRP01 | adhE ldhA iclR Δaekpta::CmR,GalP+,Kms |
PRP02 | adhE ldhA iclR,ptsHL Δaekpta::CmR,Kms |
SBSIOIOMGC | adhE,IdhA,fdhN Δaekpta::CmR,KmR |
实验1 | 实验2 | |
富氧的培养基 | LB | LB+盐添加物 |
2g/L葡萄糖 | 2g/L葡萄糖 | |
30microl/L消泡剂204 | 30microl/L消泡剂204 | |
200mg/L Ap | 200mg/L Ap | |
条件 | 37℃ | 37℃ |
500rpm | 500rpm | |
1.5L/min空气 | 1.5L/min空气 | |
pH=7.0 | pH=7.0 | |
琥珀酸盐摩尔产率 | 1.2≤ | 1.2≤ |
MIN | MIN-N | |
K2HPO4 | 0.5 | 2.8 |
K2SO4 | 1.0 | 1.0 |
KCl | 2.0 | |
(NH4)2HPO4 | 6.0 | 0.4 |
MgSO4,7H2O | 2.0 | 2.0 |
pH的调节 | NaOH | NH3 |
胰蛋白胨 | 10g/l |
酵母提取物 | 5g/l |
NaCl | 10g/l |
KH2PO4 | 3g/l |
Na2HPO4 | 6g/l |
NH4Cl | 1g/l |
MgSO4,7H2O | 0.25g/l |
NaCl | 0.5g/l |
抗生素(氨比西林、羧苄西林、苯唑西林) | 67mg/L |
葡萄糖 | 10g/l |
(NH4)2PO4 | 6g/l |
K2HPO4 | 0.5g/l |
K2SO4 | 1g/l |
KCl | 2g/l |
MgSO4.7H2O | 2g/l |
FeSO4.7H2O | 60mg/l |
CaCl2.2H2O | 30mg/l |
ZnSO4.7H2O | 4mg/l |
CuCl2.2H2O | 2mg/l |
MnSO4.H2O | 20mg/l |
CoCl2.6H2O | 8mg/l |
H3BO3 | 1mg/l |
Na2MoO4.2H2O | 0.4mg/l |
生物素 | 1mg/l |
硫胺素 | 1mg/l |
氨比西林 | 67mg/l |
(NH4)2HPO4 | 6g/l |
K2HPO4 | 0.5g/l |
K2SO4 | 1g/l |
KCl | 2g/l |
MgSO4.7H2O | 2g/l |
FeSO4.7H2O | 60mg/l |
CaCl2.2H2O | 30mg/l |
ZnSO4.7H2O | 4mg/l |
CuCl2.2H2O | 2mg/l |
MnSO4.H2O | 20mg/l |
CoCl2.6H2O | 8mg/l |
H3BO3 | 1mg/l |
Na2MoO4.2H2O | 0.4mg/l |
生物素 | 1mg/l |
硫胺素 | 1mg/l |
氨比西林 | 67mg/l |
富氧期的碱 | 富氧期的培养基 | 贫氧期 | 富氧期的pH升高 | 有氧期的比生长速率(=μ)小时-1 | 富氧期OD 600nm | CO2期琥珀酸盐产率(%g/g) | CO2期琥珀酸盐比速率(g/h/OD) |
NaOH | MIN | 是 | 有 | 0.31 | 16.6 | 92 | 0.06 |
富氧期的碱 | 富氧期的培养基 | 贫氧期 | 富氧期的pH升高 | 有氧期比生长速率(=μ)小时-1 | 富氧期的吸光度OD600nm | CO2期的琥珀酸盐产率(%g/g) | CO2期的琥珀酸盐的比速率(g/h/OD) |
NaOH | MIN | 不是 | 没有 | 0.33 | 18.0 | - | <0.01 |
NaOH | MIN | 是 | 没有 | 0.30 | 16.1 | 85 | 0.03 |
MIN | 是 | 有 | 0.31 | 16.6 | 92 | 0.06 | |
NH3 | MIN N | 不是 | 没有 | 0.39 | 22.3 | - | <0.01 |
NH3 | MIN N | 是 | 没有 | 0.33 | 17.9 | 68 | 0.05 |
NH3 | MIN N | 是 | 有 | 0.34 | 17.2 | 71 | 0.05 |
(NH4)2SO4 | 0.25g/l |
K2HPO4 | 0.7g/l |
KH2PO4 | 1.2g/l |
KCl | 2g/l |
CaCl2 | 0.2g/l |
MgSO4 | 0.25g/l |
氨比西林 | 0.067g/l |
生物素 | 0.001g/l |
硫胺素 | 0.001g/l |
Claims (16)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2007/055409 WO2009083756A1 (en) | 2007-12-28 | 2007-12-28 | Large scale microbial culture method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101918574A true CN101918574A (zh) | 2010-12-15 |
Family
ID=39869967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007801019569A Pending CN101918574A (zh) | 2007-12-28 | 2007-12-28 | 大规模的微生物培养法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8486686B2 (zh) |
EP (1) | EP2225383A1 (zh) |
JP (1) | JP2011507541A (zh) |
KR (1) | KR20100109902A (zh) |
CN (1) | CN101918574A (zh) |
BR (1) | BRPI0722315A2 (zh) |
CA (1) | CA2709515A1 (zh) |
WO (1) | WO2009083756A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120238722A1 (en) | 2009-11-24 | 2012-09-20 | Roquette Freres Sa | Process for the crystallization of succinic acid |
EP2371802A1 (en) | 2010-03-30 | 2011-10-05 | DSM IP Assets B.V. | Process for the crystallization of succinic acid |
EP2619314A1 (en) * | 2010-09-24 | 2013-07-31 | DSM IP Assets B.V. | Dicarboxylic acid production process |
CN102653779B (zh) * | 2011-03-04 | 2014-02-19 | 北京科润三联生物技术有限责任公司 | 一种新型重组抗菌多肽药物的制备方法 |
WO2014135712A2 (en) | 2013-03-08 | 2014-09-12 | Dsm Ip Assets B.V. | Polyester |
FR3028864B1 (fr) | 2014-11-26 | 2018-05-18 | Roquette Freres | Procede de recuperation de cristaux d'acide succinique avec mise en œuvre de tensioactifs au cours de la cristallisation, cristaux obtenus et leurs utilisations |
EP3227256B1 (en) | 2014-12-02 | 2019-03-13 | Roquette Freres | Process for manufacturing succinic acid from a fermentation broth using nanofiltration to purify recycled mother liquor |
WO2016137897A1 (en) | 2015-02-24 | 2016-09-01 | William Marsh Rice University | Kasiii-free fa synthesis |
EP3067378A1 (en) | 2015-03-11 | 2016-09-14 | DSM IP Assets B.V. | Polyester |
US11174468B2 (en) | 2016-04-08 | 2021-11-16 | William Marsh Rice University | Galactose utilization |
WO2017192925A1 (en) * | 2016-05-05 | 2017-11-09 | William Marsh Rice University | Improved microbial production of fats |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246155A (zh) * | 1997-01-31 | 2000-03-01 | 洛克系德·马丁能量研究有限公司 | 一种生产二羧酸的方法 |
CN1268972A (zh) * | 1997-07-31 | 2000-10-04 | 韩国科学技术研究院 | pta 1dhA双重突变大肠杆菌SS373及由其生产琥珀酸的方法 |
CN101029316A (zh) * | 2006-12-13 | 2007-09-05 | 华东理工大学 | 大肠杆菌生产琥珀酸的方法 |
CN101044245A (zh) * | 2004-08-27 | 2007-09-26 | 莱斯大学 | 具有增加的琥珀酸产量的突变大肠杆菌菌株 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034105A (en) * | 1989-07-27 | 1991-07-23 | Michigan Biotechnology Institute | Carboxylic acid purification and crystallization process |
WO2003040690A2 (en) * | 2001-11-02 | 2003-05-15 | Rice University | Recycling system for manipulation of intracellular nadh availability |
US7927859B2 (en) * | 2003-08-22 | 2011-04-19 | Rice University | High molar succinate yield bacteria by increasing the intracellular NADH availability |
US7262046B2 (en) * | 2004-08-09 | 2007-08-28 | Rice University | Aerobic succinate production in bacteria |
US20070111294A1 (en) * | 2005-09-09 | 2007-05-17 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of succinate |
JP5034630B2 (ja) * | 2007-04-12 | 2012-09-26 | 三菱化学株式会社 | 有機酸生産微生物の菌体の調製法及び有機酸の製造法 |
FR2925068B1 (fr) * | 2007-12-13 | 2010-01-08 | Roquette Freres | Procedes de production d'acide succinique |
-
2007
- 2007-12-28 WO PCT/IB2007/055409 patent/WO2009083756A1/en active Application Filing
- 2007-12-28 BR BRPI0722315-3A2A patent/BRPI0722315A2/pt not_active Application Discontinuation
- 2007-12-28 CN CN2007801019569A patent/CN101918574A/zh active Pending
- 2007-12-28 JP JP2010540180A patent/JP2011507541A/ja active Pending
- 2007-12-28 KR KR1020107013061A patent/KR20100109902A/ko not_active Application Discontinuation
- 2007-12-28 CA CA2709515A patent/CA2709515A1/en not_active Abandoned
- 2007-12-28 US US12/747,979 patent/US8486686B2/en not_active Expired - Fee Related
- 2007-12-28 EP EP07870493A patent/EP2225383A1/en not_active Ceased
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246155A (zh) * | 1997-01-31 | 2000-03-01 | 洛克系德·马丁能量研究有限公司 | 一种生产二羧酸的方法 |
CN1268972A (zh) * | 1997-07-31 | 2000-10-04 | 韩国科学技术研究院 | pta 1dhA双重突变大肠杆菌SS373及由其生产琥珀酸的方法 |
CN101044245A (zh) * | 2004-08-27 | 2007-09-26 | 莱斯大学 | 具有增加的琥珀酸产量的突变大肠杆菌菌株 |
CN101029316A (zh) * | 2006-12-13 | 2007-09-05 | 华东理工大学 | 大肠杆菌生产琥珀酸的方法 |
Also Published As
Publication number | Publication date |
---|---|
BRPI0722315A2 (pt) | 2014-06-10 |
US20100317086A1 (en) | 2010-12-16 |
CA2709515A1 (en) | 2009-07-09 |
EP2225383A1 (en) | 2010-09-08 |
US8486686B2 (en) | 2013-07-16 |
KR20100109902A (ko) | 2010-10-11 |
JP2011507541A (ja) | 2011-03-10 |
WO2009083756A1 (en) | 2009-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101918574A (zh) | 大规模的微生物培养法 | |
CN101044245B (zh) | 具有增加的琥珀酸产量的突变大肠杆菌菌株 | |
Zhang et al. | Production of L-alanine by metabolically engineered Escherichia coli | |
CN101389752B (zh) | 能够产生有机酸的细菌以及产生有机酸的方法 | |
CN101501204B (zh) | 一种利用甘油生产氨基酸的方法 | |
CN1820076B (zh) | 有机酸的制造方法 | |
CN102159702B (zh) | 生产乳酸的细菌及生产乳酸的方法 | |
KR100780324B1 (ko) | 신규 순수 숙신산 생성 변이 미생물 및 이를 이용한 숙신산제조방법 | |
US8691552B2 (en) | Microaerobic cultures for converting glycerol to chemicals | |
CN102365357A (zh) | 通过发酵产生大量乙醇酸的方法 | |
CN105189758A (zh) | 生长-诱导-生产阶段的控制 | |
CN101896613A (zh) | 用于生产琥珀酸的方法 | |
WO2009154624A1 (en) | Methods and processes for producing organic acids | |
CN105452445A (zh) | 利用用于糖输入的易化扩散生产琥珀酸和其它化学品的方法 | |
JP5805768B2 (ja) | スクロースとグリセロールとを同時に利用する新規コハク酸生成変異微生物及びこれを利用したコハク酸製造方法 | |
CN104487582A (zh) | 通过分批添加碳源底物和碱来制备有机酸的方法 | |
CN100334200C (zh) | 一株可高产谷氨酰胺的谷氨酸棒杆菌 | |
CN103717746B (zh) | 通过连续培养制造异丙醇的方法 | |
CN102333859B (zh) | 由来自植物的原料生产乳酸的方法及生产乳酸的细菌 | |
CN101821399A (zh) | 琥珀酸的制备方法 | |
CN103695512A (zh) | 一种发酵生产多粘菌素e的方法 | |
WO2009048202A1 (en) | Method for preparing succinic acid using glycerol as carbon source | |
CN106164249A (zh) | 用于基于蔗糖的改善精细化学品产生的修饰微生物 | |
CN101654666B (zh) | 用于生产d-乳酸的生物催化剂 | |
CN101029316B (zh) | 大肠杆菌生产琥珀酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: UNIV RICE WILLIAM M. Free format text: FORMER OWNER: ROQUETTE FRERES Effective date: 20130621 Free format text: FORMER OWNER: UNIV RICE WILLIAM M. Effective date: 20130621 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130621 Address after: American Houston Applicant after: Univ Rice William M. Address before: French Lester Ram Applicant before: Roquette Freres Applicant before: Univ Rice William M. |
|
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20101215 |
|
WD01 | Invention patent application deemed withdrawn after publication |